Hvivo PLC operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hvivo PLC with three other
pharmaceutical manufacturers in Europe:
Horizon Discovery Group PLC
sales of £24.07 million [US$34.54 million]
of which 53%
Venture Life Group plc
(£14.28 million [US$20.49 million]
based in Greece
(31.14 million Euro [US$38.54 million]
Sales increased substantially in 2016:
During the year ended December of 2016, sales at
Hvivo PLC were £19.85 million (US$28.48 million).
increase of 157.2%
versus 2015, when the company's sales were £7.72 million.